Kathryn N. Phoenix

973 total citations
16 papers, 758 citations indexed

About

Kathryn N. Phoenix is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Kathryn N. Phoenix has authored 16 papers receiving a total of 758 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 9 papers in Cancer Research and 7 papers in Oncology. Recurrent topics in Kathryn N. Phoenix's work include Cancer, Hypoxia, and Metabolism (6 papers), Metabolism, Diabetes, and Cancer (5 papers) and Cancer-related Molecular Pathways (3 papers). Kathryn N. Phoenix is often cited by papers focused on Cancer, Hypoxia, and Metabolism (6 papers), Metabolism, Diabetes, and Cancer (5 papers) and Cancer-related Molecular Pathways (3 papers). Kathryn N. Phoenix collaborates with scholars based in United States, Germany and United Kingdom. Kathryn N. Phoenix's co-authors include Kevin P. Claffey, Xiufang Liu, John J. Peluso, David K. Han, Daniel Rodríguez‐Pinto, B A White, Jennifer S. Tirnauer, Irene K. Guttilla Reed, Rebecca Evans and Daniel Kita and has published in prestigious journals such as Blood, Molecular and Cellular Biology and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Kathryn N. Phoenix

15 papers receiving 751 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kathryn N. Phoenix United States	11	538	259	236	76	73	16	758
Zhiming Zhang China	17	580 1.1×	238 0.9×	158 0.7×	109 1.4×	37 0.5×	53	889
Evelyn Aranda United States	11	412 0.8×	126 0.5×	210 0.9×	80 1.1×	68 0.9×	12	753
Yukiko Shibahara Japan	16	348 0.6×	227 0.9×	190 0.8×	99 1.3×	73 1.0×	40	678
Soumya Ullas United States	8	398 0.7×	138 0.5×	139 0.6×	48 0.6×	57 0.8×	11	649
Stacy A. Blaine United States	11	452 0.8×	181 0.7×	243 1.0×	75 1.0×	108 1.5×	11	739
Sun Y. Kim United States	6	319 0.6×	168 0.6×	174 0.7×	43 0.6×	97 1.3×	6	571
Marica Gemei Italy	17	371 0.7×	199 0.8×	248 1.1×	54 0.7×	31 0.4×	30	666
Katie O’Callaghan United States	11	480 0.9×	223 0.9×	153 0.6×	30 0.4×	42 0.6×	19	904
Yang Luo China	17	748 1.4×	291 1.1×	274 1.2×	95 1.3×	66 0.9×	40	1.1k
Crystal M. Weyman United States	15	506 0.9×	175 0.7×	84 0.4×	60 0.8×	62 0.8×	26	658

Countries citing papers authored by Kathryn N. Phoenix

Since Specialization

Citations

This map shows the geographic impact of Kathryn N. Phoenix's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathryn N. Phoenix with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathryn N. Phoenix more than expected).

Fields of papers citing papers by Kathryn N. Phoenix

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kathryn N. Phoenix. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathryn N. Phoenix. The network helps show where Kathryn N. Phoenix may publish in the future.

Co-authorship network of co-authors of Kathryn N. Phoenix

This figure shows the co-authorship network connecting the top 25 collaborators of Kathryn N. Phoenix. A scholar is included among the top collaborators of Kathryn N. Phoenix based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kathryn N. Phoenix. Kathryn N. Phoenix is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Phoenix, Kathryn N., et al.. (2025). Asfotase alfa restores PLP-dependent GABA, cystathionine, and amino acid metabolism in a mouse model of hypophosphatasia. Neuroscience Research. 218. 104940–104940.

Phoenix, Kathryn N., Zhichao Yue, Lixia Yue, et al.. (2022). PLCβ2 Promotes VEGF-Induced Vascular Permeability. Arteriosclerosis Thrombosis and Vascular Biology. 42(10). 1229–1241. 16 indexed citations

Jensen, Todd, et al.. (2015). Descriptive analysis of tumor cells with stem like phenotypes in metastatic and benign adrenal tumors. Journal of Pediatric Surgery. 50(9). 1493–1501. 10 indexed citations

Kita, Daniel, et al.. (2015). Patient-derived heavy chain antibody targets cell surface HSP90 on breast tumors. BMC Cancer. 15(1). 614–614. 19 indexed citations

Phoenix, Kathryn N., et al.. (2015). Abstract 1138: AMPK promotes survival of breast cancer cells by modulating metabolic stress. Cancer Research. 75(15_Supplement). 1138–1138. 1 indexed citations

Phoenix, Kathryn N., et al.. (2013). AMP-Activated Protein Kinase 2 Isoform Suppression in Primary Breast Cancer Alters AMPK Growth Control and Apoptotic Signaling. Genes & Cancer. 4(1-2). 3–14. 64 indexed citations

Phoenix, Kathryn N., et al.. (2013). Abstract 310: Role of AMPKalpha isoforms in bladder tumorigenesis.. Cancer Research. 73(8_Supplement). 310–310. 1 indexed citations

Phoenix, Kathryn N., et al.. (2012). AMPK 2 Suppresses Murine Embryonic Fibroblast Transformation and Tumorigenesis. Genes & Cancer. 3(1). 51–62. 40 indexed citations

Hoeppner, Luke H., Kathryn N. Phoenix, Karl J. Clark, et al.. (2012). Revealing the role of phospholipase Cβ3 in the regulation of VEGF-induced vascular permeability. Blood. 120(11). 2167–2173. 27 indexed citations

10.

Reed, Irene K. Guttilla, et al.. (2011). Prolonged mammosphere culture of MCF-7 cells induces an EMT and repression of the estrogen receptor by microRNAs. Breast Cancer Research and Treatment. 132(1). 75–85. 121 indexed citations

11.

Phoenix, Kathryn N., et al.. (2009). Dietary energy availability affects primary and metastatic breast cancer and metformin efficacy. Breast Cancer Research and Treatment. 123(2). 333–344. 74 indexed citations

12.

Phoenix, Kathryn N., et al.. (2009). Expression of the Cancer Stem Cell Marker ALDH1A1 in Primary Breast Cancer: A Mechanism for Chemotherapy Resistance.. Cancer Research. 69(24_Supplement). 1135–1135. 3 indexed citations

13.

Peluso, John J., et al.. (2008). Regulation of Ovarian Cancer Cell Viability and Sensitivity to Cisplatin by Progesterone Receptor Membrane Component-1. The Journal of Clinical Endocrinology & Metabolism. 93(5). 1592–1599. 118 indexed citations

14.

Phoenix, Kathryn N., et al.. (2008). Therapeutic metformin/AMPK activation promotes the angiogenic phenotype in the ERα negative MDA-MB-435 breast cancer model. Breast Cancer Research and Treatment. 113(1). 101–111. 139 indexed citations

15.

Rodríguez‐Pinto, Daniel, Jason Sparkowski, Martin P. Keough, et al.. (2008). Identification of novel tumor antigens with patient-derived immune-selected antibodies. Cancer Immunology Immunotherapy. 58(2). 221–234. 24 indexed citations

16.

Phoenix, Kathryn N., et al.. (2007). Double-Stranded RNA-Binding Protein Regulates Vascular Endothelial Growth Factor mRNA Stability, Translation, and Breast Cancer Angiogenesis. Molecular and Cellular Biology. 28(2). 772–783. 101 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact